BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 24977448)

  • 1. [CXCR4: a new therapeutic target of the leukaemic cell? Role of the SDF-1/CXCR4 axis in acute myeloid leukaemia].
    Tavernier E; Aanei C; Solly F; Flandrin-Gresta P; Campos L; Guyotat D
    Bull Cancer; 2014 Jun; 101(6):593-604. PubMed ID: 24977448
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dissecting the role of the CXCL12/CXCR4 axis in acute myeloid leukaemia.
    Ladikou EE; Chevassut T; Pepper CJ; Pepper AG
    Br J Haematol; 2020 Jun; 189(5):815-825. PubMed ID: 32135579
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting the microenvironment in acute myeloid leukemia.
    Rashidi A; Uy GL
    Curr Hematol Malig Rep; 2015 Jun; 10(2):126-31. PubMed ID: 25921388
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional response of leukaemic blasts to stromal cell-derived factor-1 correlates with preferential expression of the chemokine receptor CXCR4 in acute myelomonocytic and lymphoblastic leukaemia.
    Möhle R; Schittenhelm M; Failenschmid C; Bautz F; Kratz-Albers K; Serve H; Brugger W; Kanz L
    Br J Haematol; 2000 Sep; 110(3):563-72. PubMed ID: 10997965
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Can inhibition of the SDF-1/CXCR4 axis eradicate acute leukemia?
    Tavor S; Petit I
    Semin Cancer Biol; 2010 Jun; 20(3):178-85. PubMed ID: 20637871
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting the leukemia microenvironment by CXCR4 inhibition overcomes resistance to kinase inhibitors and chemotherapy in AML.
    Zeng Z; Shi YX; Samudio IJ; Wang RY; Ling X; Frolova O; Levis M; Rubin JB; Negrin RR; Estey EH; Konoplev S; Andreeff M; Konopleva M
    Blood; 2009 Jun; 113(24):6215-24. PubMed ID: 18955566
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of CXCR4 in the progression and therapy of acute leukaemia.
    Su L; Hu Z; Yang YG
    Cell Prolif; 2021 Jul; 54(7):e13076. PubMed ID: 34050566
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CXCR4 regulates migration and development of human acute myelogenous leukemia stem cells in transplanted NOD/SCID mice.
    Tavor S; Petit I; Porozov S; Avigdor A; Dar A; Leider-Trejo L; Shemtov N; Deutsch V; Naparstek E; Nagler A; Lapidot T
    Cancer Res; 2004 Apr; 64(8):2817-24. PubMed ID: 15087398
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting CXCR4/SDF-1 axis by lipopolymer complexes of siRNA in acute myeloid leukemia.
    Landry B; Gül-Uludağ H; Plianwong S; Kucharski C; Zak Z; Parmar MB; Kutsch O; Jiang H; Brandwein J; Uludağ H
    J Control Release; 2016 Feb; 224():8-21. PubMed ID: 26742943
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A CXCR4 antagonist leads to tumor suppression by activation of immune cells in a leukemia-induced microenvironment.
    Han AR; Lee JY; Kim HJ; Min WS; Park G; Kim SH
    Oncol Rep; 2015 Dec; 34(6):2880-8. PubMed ID: 26398122
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The central role of the chemokine receptor, CXCR4, in haemopoietic stem cell transplantation: will CXCR4 antagonists contribute to the treatment of blood disorders?
    Watt SM; Forde SP
    Vox Sang; 2008 Jan; 94(1):18-32. PubMed ID: 18042197
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of CXCR4 in the pathogenesis of acute myeloid leukemia.
    Peled A; Tavor S
    Theranostics; 2013; 3(1):34-9. PubMed ID: 23382784
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The role of stromal cell-derived factor and its receptor-CXCR4 in G-CSF-induced hematopoietic stem cell mobilization].
    Jin FY; Qiu LG; Li QC; Meng HX; Wang YF; Yu Z; Li Q; Han JL
    Zhonghua Xue Ye Xue Za Zhi; 2007 Feb; 28(2):98-102. PubMed ID: 17650669
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of stromal-derived factor-1 in the hematopoietic-supporting activity of human mesenchymal stem cells.
    Van Overstraeten-Schlögel N; Beguin Y; Gothot A
    Eur J Haematol; 2006 Jun; 76(6):488-93. PubMed ID: 16494621
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The role of the SDF-1-CXCR4 axis in hematopoiesis and the mobilization of hematopoietic stem cells to peripheral blood].
    Gieryng A; Bogunia-Kubik K
    Postepy Hig Med Dosw (Online); 2007 Jun; 61():369-83. PubMed ID: 17572657
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stromal cell-derived factor-1 (SDF-1) as a target in liver diseases.
    Liepelt A; Tacke F
    Am J Physiol Gastrointest Liver Physiol; 2016 Aug; 311(2):G203-9. PubMed ID: 27313175
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting the CXCL12/CXCR4 axis in acute myeloid leukemia: from bench to bedside.
    Cho BS; Kim HJ; Konopleva M
    Korean J Intern Med; 2017 Mar; 32(2):248-257. PubMed ID: 28219003
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CXCR4 chemokine receptors (CD184) and alpha4beta1 integrins mediate spontaneous migration of human CD34+ progenitors and acute myeloid leukaemia cells beneath marrow stromal cells (pseudoemperipolesis).
    Burger JA; Spoo A; Dwenger A; Burger M; Behringer D
    Br J Haematol; 2003 Aug; 122(4):579-89. PubMed ID: 12899713
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CXCL12 and CXCR4 in bone marrow physiology.
    Moll NM; Ransohoff RM
    Expert Rev Hematol; 2010 Jun; 3(3):315-22. PubMed ID: 21082982
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of SDF-1-CXCR4/CXCR7 axis in biological behaviors of adipose tissue-derived mesenchymal stem cells in vitro.
    Li Q; Zhang A; Tao C; Li X; Jin P
    Biochem Biophys Res Commun; 2013 Nov; 441(3):675-80. PubMed ID: 24184476
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.